Literature DB >> 16909032

Neuronal differentiation of human umbilical cord blood neural stem-like cell line.

Leonora Buzańska1, Marcin Jurga, Krystyna Domańska-Janik.   

Abstract

The expanding population of neural stem/progenitor cells can be selected from human cord blood nonhematopoietic (CD34-negative) mononuclear fraction. Due to repeated expansion and selection of these cells we have established the first clonogenic, nonimmortalized human umbilical cord blood neural stem-like cell (HUCB-NSC) line. This line can be maintained at different stages of neural progenitor development by the presence of trophic factors, mitogens and neuromorphogens in culture media. Neurogenic potential of HUCB-NSC was established for serum-free and low-serum cultured cells. Commitment of HUCB-NSC by serum was shown to be important for the optimal response to the signals provided by surrounding environment in vitro. Enhanced neuronal differentiation induced by dBcAMP treatment was accompanied by expression of several functional proteins including glutamatergic, GABAergic, dopamine, serotonin and acetylcholine receptors, which was shown by microarray, immunocytochemistry and electrophysiology. Electrophysiological studies, whole-cell patch-clamp recordings, revealed in differentiated HUCB-NSC two types of voltage-sensitive and several ligand-gated currents typical for neuronal cells. The above HUCB-NSC characteristic conceivably implicates that cord blood-derived progenitors could be effectively differentiated into functional neuron-like cells in vitro. Copyright (c) 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2006        PMID: 16909032     DOI: 10.1159/000092088

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  13 in total

Review 1.  Very small embryonic-like stem cells: biology and therapeutic potential for heart repair.

Authors:  Ewa K Zuba-Surma; Wojciech Wojakowski; Mariusz Z Ratajczak; Buddhadeb Dawn
Journal:  Antioxid Redox Signal       Date:  2011-05-05       Impact factor: 8.401

Review 2.  Pathophysiology and neuroprotection of global and focal perinatal brain injury: lessons from animal models.

Authors:  Luigi Titomanlio; David Fernández-López; Lucilla Manganozzi; Raffaella Moretti; Zinaida S Vexler; Pierre Gressens
Journal:  Pediatr Neurol       Date:  2015-01-31       Impact factor: 3.372

3.  Cell Therapy From Bench to Bedside Translation in CNS Neurorestoratology Era.

Authors:  Hongyun Huang; Lin Chen; Paul Sanberg
Journal:  Cell Med       Date:  2010-01-01

Review 4.  Repairing neural injuries using human umbilical cord blood.

Authors:  Tao Sun; Quan-Hong Ma
Journal:  Mol Neurobiol       Date:  2012-12-30       Impact factor: 5.590

5.  Non-hematopoietic stem cells in umbilical cord blood.

Authors:  Taro Matsumoto; Hideo Mugishima
Journal:  Int J Stem Cells       Date:  2009-05       Impact factor: 2.500

6.  Application of Umbilical Cord Blood Derived Stem Cells in Diseases of the Nervous System.

Authors:  Bhagelu R Achyut; Nadimpalli Ravi S Varma; Ali S Arbab
Journal:  J Stem Cell Res Ther       Date:  2014

Review 7.  Neonatal Encephalopathy: Update on Therapeutic Hypothermia and Other Novel Therapeutics.

Authors:  Ryan M McAdams; Sandra E Juul
Journal:  Clin Perinatol       Date:  2016-06-22       Impact factor: 3.430

8.  Characterization of ionic currents in human neural stem cells.

Authors:  Chae Gil Lim; Sung-Soo Kim; Haeyoung Suh-Kim; Young-Don Lee; Seung Cheol Ahn
Journal:  Korean J Physiol Pharmacol       Date:  2008-08-31       Impact factor: 2.016

Review 9.  Stem cells and neurological diseases.

Authors:  D C Hess; C V Borlongan
Journal:  Cell Prolif       Date:  2008-02       Impact factor: 6.831

Review 10.  Systemic delivery of umbilical cord blood cells for stroke therapy: a review.

Authors:  Guolong Yu; Cesar V Borlongan; Christine E Stahl; David C Hess; Yali Ou; Yuji Kaneko; Seong Jin Yu; Tianlun Yang; Li Fang; Xiumei Xie
Journal:  Restor Neurol Neurosci       Date:  2009       Impact factor: 2.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.